NCT02773290View on ClinicalTrials.gov

Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 14, 2017

Study Completion Date

July 28, 2020

Conditions
Aplastic Anemia
Interventions
BIOLOGICAL

Romiplostim

Weekly SC administration

Trial Locations (3)

Unknown

Kanazawa

Tokyo

Seoul

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT02773290 - Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia | Biotech Hunter | Biotech Hunter